ArticleScience advances2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2.
Nicolai D Raig et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleScience advances2025
Nicolai D Raig et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.